Nükleer Tıp

Uzm. Dr. Aziz Nazaroğlu

Hekim ve araştırmacı Dr. İsmail Fehmi Cumalıoğlu Şehir Hastanesi Tekirdağ
Kurum sayfasını aç
Düzeltme öner

Bu sizin profiliniz mi? Sahiplenin, bilgilerinizi doğrulayın.

Profili sahiplen

Güven

Bu bilgiler nereden geliyor?

Her bilginin yanında kaynağı yazar. Yanlış bir şey görürseniz düzeltme önerebilirsiniz.

  • UzmanlıkNükleer Tıpsaglik.gov.trKaynaktan
  • KurumDr. İsmail Fehmi Cumalıoğlu Şehir Hastanesisaglik.gov.trKaynaktan
  • Yayınlar10 yayınORCIDKaynaktan
  • ORCID0000-0002-3052-9314ORCIDKaynaktan
  • Son eşitleme5 Kasım 2026 10:37https://tekirdagsehir.saglik.gov.tr/TR-584399/doktorlarimiz.html#aziz-nazaroglusaglik.gov.tr

Bilimsel çalışmalar

Yayınlar

10 yayın

  1. Beyond tumor burden: PET/CT-derived psoas muscle quality and survival outcomes in metastatic NSCLC patients treated with nivolumab.

    BMC cancer, 2026

    DOI 10.1186/s12885-026-16210-z PMID 42192342 Açık erişimli tam metinKaynak: ORCID

  2. Incidental Findings on 18F-Fluorocholine PET for Parathyroid Imaging

    European Journal of Nuclear Medicine and Molecular Imaging, 2023

    Kaynak: ORCID

  3. The contribution of PET/MR in benign malignant nodule separation in thyroid incidentalomas detected in FDG PET/CT imaging

    European Journal of Nuclear Medicine and Molecular Imaging, 2022

    Kaynak: ORCID

  4. Using Visual Recognition Based Machine Learning For The Prediction Of Survival In Patients With Colorectal Cancer With Liver Metastasis

    European Journal of Nuclear Medicine and Molecular Imaging, 2022

    Kaynak: ORCID

  5. Can FDG PET Predict Covid 19 Disease Severity and Discharge Time

    European Journal of Nuclear Medicine and Molecular Imaging, 2021

    Kaynak: ORCID

  6. Evaluation of thyroid function in patients receiving Lu-177 DOTATATE treatment

    European Journal of Nuclear Medicine and Molecular Imaging, 2021

    Kaynak: ORCID

  7. Evaluation of treatment efficiency in 301 patients with hyperthyroidism treated with a single dose of I-131 as outpatient

    European Journal of Nuclear Medicine and Molecular Imaging, 2021

    Kaynak: ORCID

  8. The Effectiveness of 177Lu-DOTA TATE in Radioiodine-Refractory Differentiated Thyroid Cancer

    European Journal of Nuclear Medicine and Molecular Imaging, 2020

    Kaynak: ORCID

  9. The effectiveness of 177Lu-DOTATATE in patients with metastatic medullary thyroid cancer

    European Journal of Nuclear Medicine and Molecular Imaging, 2020

    Kaynak: ORCID

  10. The efficacy of Lu177-PSMA treatment at chemotherapy-naive metastatic prostate cancer

    European Journal of Nuclear Medicine and Molecular Imaging, 2020

    Kaynak: ORCID